Insights & Updates

Drug discovery has always involved making high-stakes decisions before all the answers are available. The challenge for R&D leadership is determining which uncertainties are acceptable, and which are systemic liabilities capable of derailing an entire program at the clinical threshold.

Neurology is one of the most complex and challenging frontiers in medicine, encompassing a vast spectrum of disorders that affect the central and peripheral nervous system, behavioral and mood changes, and extending changes in hormones and the microbiome. This includes progressive neurodegenerative conditions like Alzheimer’s Disease and Parkinson’s Disease, defined by the toxic aggregation of proteins like Amyloid-beta and alpha-synuclein; autoimmune disorders like Multiple

Human Tissue Analysis in CNS drug development helps to bridge the translational gap and de-risk clinical development. New research on Alzheimers Disease, Palsy, Parkinsons, Multi System Atrophy and more offer insights into treatment development.